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ABSTRACT  
Respiratory syncytial virus (RSV) is a negative-sense, single-strand RNA virus 
that affects the upper and lower respiratory system in humans. Currently, RSV is the 
leading cause of infant mortality worldwide, while also infecting target populations of the 
elderly and immunocompromised. Significant efforts towards vaccine development have 
been made due to limited therapeutic options, however, physical instabilities of RSV may 
hinder movement in vaccine development. We hypothesize that strain-specific 
differences in stability likely attribute to differences in RSV F protein, as proposed by 
previous studies about the intrinsically instability of RSV. A panel of recombinant RSV 
viruses were analyzed for strain-specific differences through the characterization of 
physical stability amongst RSV A and B strains that differed in viral attachment proteins 
G and F expression tested against various pH solutions. Minimal variations were 
observed between RSV strains when exposed to pH. This study will provide further 
information on the role of RSV F protein in virus stability and guidance on design of a 
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INTRODUCTION  
General Virology 
A virus is non-living obligate, intracellular parasite. While a virus is not 
characterized as a living organism, a virus still maintains several aspects and functions 
that pertain to life. A virus shares the following properties with all living organisms: 
exhibiting structural organization, the ability to adapt, and replicate/reproduce. However, 
other life functions such as metabolism, growth, homeostasis, and response to stimuli all 
require the virus to infect a host. When the virus is not in a host it is referred to as a 
virion, which exhibits not biological activity.  
 
Virus Structure and Stability  
 Primary viral components of structure include a capsid, envelope, the viral 
genome, and attachment protein. Together these elements comprise a virion that is able to 
remain inert outside a host, but upon immediate contact with a host, cause infection, 
replicate, and lysis of the host to create more virions. These structural proteins play 
integral roles to the protection of the genome and the delivery of the genome during 
infection. Protection of the genome involves the assembly of a stable, protective protein 
shell, specific recognition and packaging of the genome, and interaction with host cell 
membranes to form envelopes. Delivery of the genome during the infection requires 
binding to host cell receptors, uncoating of the genome, facilitating fusion with cell 
membranes and virus, and the transport of the genome to desired cellular sites. These 
functions are critical to the structure-function relationship seen in virus structure.  
  Nosek  8 
The capsid is the protein coat protecting the genome. Occasionally, the capsid 
caries accessory proteins of various functions. While every virion requires a capsid, it 
does not always need an envelope. A viral envelope is composed of host-derived lipid 
membrane from a variety of cell sources. The envelope is often stabilized by one or more 
layers of viral proteins directly beneath the membrane surface, called a matrix. These 
interactions between the envelope and matrix provide the shape of the virion.  The 
envelope also offers extra protection and stability when the virus is in its virion state. The 
attachment protein, or spikes, recognize one or more specific host cell receptors. 
Attachment proteins are critical to attachment in viral pathogenesis and often mediate 
tropism, or the spectrum of cells of a host that the virus may infect. The final component 
of virus structure is the genome of the virus, which can be either RNA or DNA (FIGURE 
1). The type of genome a virus has will control the replication strategy used by the virus. 
The genome can vary in size and organization, a relationship further demonstrated by the 
Eigen trap. The Eigen trap demonstrates the correlation between replication fidelity, 
complexity, and genome size (FIGURE 2). As the genome changes, so does the stability 
and functionality of the virus, typically with increasing size.  
Thermodynamics are also involved in determining the stability of the virus 
structure. Viral particles exhibit metastability, which is a stable structure but not at the 
most energetically favorable state. By producing this metastable state, the virus is able to 
both protein the genome and resist external damaging forces. This state also provides the 
ability for the virus to disassemble quickly and uncoat during infection. Since the 
minimum free energy conformation state has not been attained by the virus particle, it 
maintains the ability to hold potential energy in the packaged formations. However, the  
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FIGURE 1: Baltimore Classification System Schematic (Charon, 2015)  
The image above demonstrates the how viruses are classified into groups based upon 
replication pathway and genome type. Each group has a different type of genome that can 
undergo a different path to make mRNA with is then synthesized into proteins.  
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FIGURE 2: Eigen Trap (Nga et al., 2011) 
The Eigen trap demonstrates the relationship present between complexity, genome size, 
and replication fidelity, or the ability to replicate with minimal mutations or errors. As the 
triangle increases with size, so does the stability of the virus.  
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metastability of a virus particle acts like a switch. If given enough activation energy from 
a host trigger, such as chemical or physical trigger, the virus will increase in stability 
through undergoing a conformational change resulting in attachment, host entry, 
disassembly and uncoating.  
Metastability further relates to virus structure and function through the 
symmetrical arrangement of identical protein subunits to promote maximal protein 
contacts, promoting a metastable structure through repeating subunits of structural 
proteins. These repeating subunits then to form the capsid in either helical or icosahedral 
symmetry. Larger virions and capsid structures are often composed of multiple types of 
repeating subunits which contribute to specialized roles within the structure such as 
attachment, capsid stabilization, or genomic packaging.  
 
Pathogenesis  
Infection of host takes place in roughly five steps in which the structure and 
pathogenesis of the virus reveal key characteristic traits in regard to attachment, copying 
and spreading the genome, production of virus particles, and release. Pathogenesis begins 
with attachment of the virus to the host cell in which the virus exhibits an attachment 
protein to bind with a specific host receptor. Entry follows in which the virus will pass 
through the host membrane to enter the cell. Entry occurs through many differing 
mechanisms including fusion and receptor-mediated endocytosis under various 
environmental conditions. After entry, the virus will “uncoat”, or release the genome 
from the protective capsid structure, to all for the next step, biosynthesis. In this step, 
replication, transcription, and translation can occur. Biosynthesis for viruses differ 
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depending on the type of genome a virus has allowing for further classification of the 
virus. There are seven different types of biosynthesis pathways that each match with the 
seven different types of genomes a virus can display. The classification system used to 
describe these steps for each genome is called the Baltimore classification system. Once 
the genome has produced another copy, assembly of a new virus particle will take place 
and then be released through various different pathways. Understanding virus structure 
and pathogenesis at high level will provide future answers on how to best combat viral 
infections and produce effective therapeutics, like vaccines and antiviral drugs.  
 
Phenotypic Signs of a Viral Infection 
When a viral infection occurs, there are several ways to visualize and demonstrate 
the infection process within a lab setting through various experiments, microscopy 
techniques and mathematical calculations. Since viruses are usually less than 0.2 µm in 
size, most commercially available microscopes do not have a high enough magnification 
to view the virus in the host. It is important to note that the size of the virus does not 
correlate to ecological niche nor to disease potential. However, other methods such as 
identifying key cytopathic effects will help illustrate a viral infection taking place. 
Cytopathic effects (CPE) are cell morphological changes due to viral infection. Each 
virus has distinct set of morphological changes associated with infection and these 
defining changes in the cell culture aid in differentiating the type of virus and stage of 
infection. Syncytia is a common type of CPE that is associated with paramyxoviruses and 
coronaviruses. Syncytia form from direct cell-to-cell fusion due to the attachment 
proteins of the virus lining infected cells (FIGURE 3). The formation of these syncytia  










FIGURE 3: RSV Virion Structure (top; Moore et al., 2013) and Syncytia Formation 
in Cell Culture (bottom; Unpublished) 
The top image depicts an RSV virion where the RSV F proteins can faintly be seen on the 
exterior of the virion.  The bottom image depicts syncytia formation triggered by F 
protein expression on the surface of infected cells. Image taken using phase-contrast 
microscopy and a Texas Red filter for viral expression of the reporter, monomeric 
Katushka 2 (mKate2), at 48 h post-infection with RSV-A2-91-09GF in HEp2 cells. 
 
Moore et al. Curr Opin Immunol (2013) 6:761
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increase the rate of the viral infection, aid in viral spread, and help acquisition cell 
materials to continue virus particle production. Experiments that utilize to formation of 
syncytia to monitor the infection are referred to as plaque assays and are quantified 
through either plaque forming units/mL (PFU) or fluorescent focus units/mL (FFU).  
Through utilizing these experiments, analyzing physical stability of a virus can be further 
understood.  
 
Respiratory Syncytial Virus (RSV) 
 The Pneumoviridae family is home to large, enveloped negative strand RNA 
viruses containing pathogens native to humans, mammals, and aves (Rima et al, 2019). 
Respiratory syncytial virus (RSV) is a human pneumovirus that causes upper and lower 
respiratory disease in infants, elderly, and immunocompromised individuals (Nair et al, 
2013; Scheltema et al., 2017; Hall et al., 2009). RSV is the current leading cause of infant 
mortality worldwide (FIGURE 4) and causes many hospitalizations a year (FIGURE 5) 
(Stobart et al., 2016). Transmission of disease is horizontal and occurs mainly through 
contact and airborne routes (Rima et al., 2019).  
The general morphology and genomic composition as seen in FIGURE 6 of the 
viruses found in this family are comparable to RSV strain A2 in that virions consist of 
both spherical and filamentous structures (Rima et al, 2019). RSV is an enveloped, 
negative sense RNA virus (-ssRNA) in the Pneumoviridae family with a genome size of 
approximately 16 kb. The genome is composed of 10 genes encoding for 11 proteins 
(Collins et al., 2011). The two glycoproteins are critical to help mediate viral attachment 
(G) and fusion (F) during attachment and entry during the RSV infection. Viruses contain  




FIGURE 4: Pie Chart Demonstrating Various Causes of Infant Mortality Between 1 
and 12 Months of Age (Lozano et al. (2012) 
The figure above demonstrates the various causes of infant mortality within the first year 
of life. Lower respiratory infections count for 20.1% of mortality with 6.7% attributed to 
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FIGURE 5: Number of Hospitalizations per Patient Age for RSV (Nair et al., 2010 
and Hall et al., 2009)  
The figure above demonstrates the breakdown of hospitalizations into age groups. 
Hospitalizations for RSV in the U.S. seem to increase at 3 months old and drop off 
significantly after 2 years of age. This graphic also highlights the target populations of 
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FIGURE 6: Respiratory Syncytial Virus (RSV) Genome and Functional Gene 
Expression (Collins and Melero, 2011)  
The image above demonstrates the genes and proteins formed by RSV exemplifying their 
function and length in the genome. Important proteins to take note of are the role of 
proteins F and G in their ability to mediate attachment and fusion of the virus, along with 
eliciting an immune response of the production of neutralizing and protective antibodies.  
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an envelope derived from the host cell plasma membrane through budding in addition to 
containing transmembrane viral glycoproteins (Rima et al, 2019). A matrix protein is 
present forming a non-glycosylated membrane with additional matrix proteins (M2-1) 
(Rima et al, 2019). The glycosylated transmembrane surface proteins include the F 
protein, G protein, and SH protein (Rima et al., 2019). While the RSV F and G proteins 
play critical roles in mediating attachment and eliciting immunogenicity, the significant 
role of the SH protein remains unknown. RSV F protein controls viral penetration and 
fusion, along with being the most immunogenic. This protein is able to undergo a 
conformational change from pre-fusion to post-fusion form which is largely responsible 
for the formation of neutralizing antibody production (McLellan et al., 2013). RSV F is 
aided by RSV G, the protein responsible for viral attachment and binding (Kwilas et al., 
2009). RSV G is slightly immunogenic despite decreased efficiency of neutralizing 
antibodies produced against it (Olmsted et al., 1986). Antigenicity of RSV is made 
composed of two subgroups, named A and B, which exhibit genome wide divergence in 
nucleotide and amino acid sequence identity (Rima et al., 2019). Between the subgroups, 
the RSV F protein has 89% amino acid sequence identity similarity, whereas RSV G has 
53% (Rima et al., 2019) (FIGURE 7).  
During fusion, RSV F undergoes a dynamic conformational change activated by 
attachment from a metastable pre-fusion to post-fusion form (Collins et al., 2011). RSV F 
and G are major viral surface proteins that continue to be key activators of an 
immunogenic targets of host immune system creating vast amounts of neutralizing 
antibodies against RSV (Collins et al., 2011; Kiss et al., 2014; Lilieroos et al., 2013; 
Ngwuta et al., 2015). Recent studies have illustrated structures of the RSV F protein in  
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FIGURE 7: Alignment of RSV F Protein Sequences (Deford et al., 2019) 
The above alignment contains the viral strains used in this study and shows the sequence 
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the pre-fusion and post-fusion state leading to renewed efforts in vaccine design due to 
the critical role RSV F plays in the infection pathway (Krarup et al., 2015; McGinnes 
Cullen et al., 2015; McLellan et al., 2013; McLellan et al., 2013). While vaccines have 
may efficacious effects in other populations, previous experiments regarding an RSV 
vaccine in the 1960s which induced higher levels of disease in infants, grossly setting the 
field back (Meng et al., 2014; Kapikian et al., 1969; Kim et al., 1969). Since that time, 
current strategies to help develop vaccine have included live-attenuated and live-vectored 
remain the only vaccine designs that have not demonstrated enhanced disease in naïve 
individuals (Wright et al., 2007; Karron et al., 2013). However, instability and 
complexity of RSV structure have remained obstacles to design and development in 
vaccine efforts. Characterizing these instabilities as they relate to environmental factors 
and conditions will provide more information to aid in vaccine design, storage, and 
production.  
 
RSV Physical Stability and Project Goals 
RSV physical stability was first tested by in 1964 using the Long laboratory strain 
to conduct studies on pH and temperature (Hambling, 1964). This study demonstrated the 
RSV Long strain pH lability illustrating greatest tolerance to neutral pH (pH=7), with 
limited tolerance and presence at slightly acidic and slightly basic pHs as well. Despite 
these studies using general conditions of optimal RSV stability, they limited to the study 
of single viral strain. Another study completed in 2016 by Stobart et al., demonstrated 
that RSV F glycoprotein plays a critical role in controlling the stability of the virus as 
shown through viral strains A2 and A2-line19F (Stobart et al., 2016). These studies 
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indicate that RSV is inherently unstable and there is potential for strain specific 
differences in the RSV F protein. The goal of this study is to evaluate a panel of 
recombinant RSV strains that differ only in the expression of viral attachment protein (G) 
and viral fusion protein (F) to more clearly understand surface protein roles in the process 
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MATERIALS AND METHODS 
Cell and Viruses 
Hep-2 cells were cultured in minimal essential medium (MEM) with 10% FBS, 
1µg/mL-1 of antibiotic mixture including penicillin, streptomyocin, and amphotericin B. 
The recombinant viruses used in this study express monomeric Katushka 2 (mKate2), a 
far-red reporter gene, which allows for red fluorescence when viewed using a fluorescent 
microscopy (FIGURE 8). These viruses were recovered using a reverse genetics A2 
background with differences in only the F and/or G genes (Stobart et al., 2016). The 
following panel of recombinant RSV viruses were used in this study: A2-mKate2, A2-
mKate-line19F, A2-mKate2-(A/1998/12-21)GF [A2-12-21FG], A2-mKate-(Riyadh 
A91/2009)GF [A2-91/09GF], and A2-mKate2-(TX11-56)GF [A2-TX11-56GF]. A2-
TX11-56GF expresses RSV B fusion and attachment proteins, whereas all the other 
express RSV A fusion and attachment proteins. Virus stocks of all strains were 
propogated from low passage stocks of Hep-2 cells, frozen using dry-ice – isopropanol 
slurry and stored at -80°C until use.  
 
Virus Titering 
Virus and pH aliquot mixture were taken after incubation with virus after a given 
time allotment and serial diluted in PBS and HEPES mixture in 96 well plates. 30 µL of 
virus aliquot was added to 270 µL of PBS and HEPES solution to dilute by powers of 10. 
HEp2 cells grown in 96 well plates were used to plate the virus. HEp2 cell media was 
dumped and then 150 µL of serially diluted virus aliquot was added. Internal replicates  
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FIGURE 8: Schematic of RSV Genome and Panel of Recombinant RSV Viruses 
(DeFord et al., 2019) 
(A)The viral strains used in this study all express monomeric Katushka 2 (mKate2), a far-
red fluorescent reporter, and the F and G genes of alternative laboratory or clinical 
isolates. (B) Constructs created from clinical or laboratory isolates created using RSV 
A2-based reverse genetics system (17,18). Strain types are denoted as A or B and provide 
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were used for each aliquot. Plates were then incubated for 24 hours and fluorescent 
microscopy was used for visualization of infection and replication.  
 
RSV pH Inactivation Assays  
Several aliquots of each stain of virus were individually combined in 15mL conical tubes 
and mixed with buffer solutions at pH of 2, 3, 5, 7, 9 and 12 to create a wide range 
constant time experiment. All viruses were incubated at 37°C for 1 hour before titrating. 
Similarly, a pH time course used several aliquots of each strain of virus and subjected 
them to pH of 5.8, 6.6, and 7.4 for 0, 6, 12 and 24 hours post-incubation. After 
incubation, aliquots of the virus were serially diluted in PBS and titrated using f.f.u. 
quantification assay 24 hours post-infection on Hep-2 cells.  
 
Statistical Analyses 
The pH wide range experiment log-transformed data were fit with a three-parameter 
Gaussian curve by least squares with parameters estimated for each strain. Parameters 
were estimated by (1) center point (pH of the highest growth), (2) standard deviation and 
(3) peak height. Stain parameter estimates for all models with non-overlapping 95% 
confidence intervals were significantly different at the P<0.05 level. All models were fit 
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RESULTS  
Generating RSV Viruses  
A panel of recombinant RSV virus strains was generated at Emory University 
using a bacterial artificial chromosome (BAC) as previously described (Hotard et al., 
2012; Stobart et al., 2016). Each of the viruses is based on the RSV A2 strain and 
expresses a monomeric Katushka 2 (mKate2) fluorescent reporter protein that is detected 
in the Texas Red range. In addition, substitutions for the F and G genes of known 
circulating strains of RSV A and B strains were introduced to yield a panel of viruses that 
differ largely in their surface expression (FIGURE 8). These viruses were analyzed by 
Darby DeFord for their replication potential and ability to form syncytia and were shown 
to exhibit F- and G-associated differences in their phenotypes (FIGURE 9). 
 
Stability of RSV Strains in Across a Wide Range of pHs 
The G and F proteins mediate RSV attachment and fusion. In many different viral 
systems, variation in pH plays a key role in stabilization, inactivation and triggering the 
process of fusion between a host cell and virus. To initially investigate the impact of pH 
on virus stability and the roles of F and G in providing pH-based stability, the panel of 
viruses were exposed to a wide range of pHs for a fixed period of time. To identify the 
range of pH values that can be tolerated by RSV, all 5 viral strains were exposed to 1 
hour incubation at 37°C in pH buffers ranging from 2 to 12 (FIGURE 10). The panel of 
RSV viruses revealed that all strains had the highest retention of infectious titers at a pH 
of 7. Detectable, but less stable, virus was observed for all strains at pH of 5 and 9. No 
significant difference was observed between pH sensitivity and virus strains tested.  




FIGURE 9. RSV replication kinetics and infectivity of a panel of recombinant RSV 
strains differing in G and/or F expression in HEp2 cells (DeFord et al., 2019) 
RSV titers were calculated by quantification of fluorescent foci after infection with an 
MOI = 0.01 in HEp-2 cells. Symbols (black for A2, dashed for A2 line19F, orange for 
12–21, green for 91/09, and red for TX11-56) show the mean titers at each time point and 
error bars represent the SEM of 2+ experimental replicates. (b) Representative images 
observed over 4 days during infection in HEp2 cells with mKate2 expression detected 
using a Texas Red filter. The point of monolayer dissociation for each strain is denoted 
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FIGURE 10: Wide Range pH Exposure to Panel of Recombinant RSV Strains  
The RSV panel was incubated at 37°C for 1 hour at pHs 2, 3, 5, 7, 9 and 12 before f.f.u. 
titer determination on HEp-2 cells. All strains demonstrated the highest titer at a pH of 7. 
Error bars indicate the mean percent reductions in titer compared to that of pH 7. No 
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Impacts of Time at Different Physiological pHs on RSV Stability 
Previous studies have evaluated that the physiologic pH of the airway surface 
liquids of the upper and lower respiratory tract have illustrated values from 5.5 to 8.0. To 
evaluate how pH variations effect the replication ability of the RSV over time, the panel 
of viruses were incubated in physiologically relevant pHs of 5.8, 6.8, and 7.4 (FIGURES 
11 - 13). Titers were detectable for all five viral strains after 24 hours of incubation 
except for A2-TX1156GF. This was consistent with previous studies regarding thermal 
stability as A2-TX1156GF did not have observable titers in all 3 pH solutions after 24 
hours of incubation. The half-life for each virus was calculated for the five strains at 37°C 
and were found to be 1.38, 1.54, and 1.51 hours for pHs 5.8, 6.8, and 7.4 respectively. 
While this data indicate maximal stability at more neutral pHs, no significant differences 
were observed between strains in all pH buffers, which is consistent with incubations 





















  Nosek  29 
 
FIGURE 11: Exposure of Recombinant RSV Strains to pH 5.8 over 24 hours  
Viral strains were incubated in a pH buffer of 5.8 over a period of 24 hours before f.f.u. 
titering on Hep-2 cells. Percent reductions in titer were reported for each time relative to 
the titer as determined before incubation (day 0). Error bars represent mean percent 
reductions in titer compared to hour 0. No statistically significant difference was 
observed between strains at any pH level.  
 
  Nosek  30 
 
FIGURE 12: Exposure of Recombinant RSV Strains to pH 6.6 over 24 hours  
Viral strains were incubated in a pH buffer of 6.6 over a period of 24 hours before f.f.u. 
titering on Hep-2 cells. Percent reductions in titer were reported for each time relative to 
the titer as determined before incubation (day 0). Error bars represent mean percent 
reductions in titer compared to hour 0. No statistically significant difference was 
observed between strains at any pH level.  
  Nosek  31 
 
FIGURE 13: Exposure of Recombinant RSV Strains to pH 7.4 over 24 hours  
Viral strains were incubated in a pH buffer of 7.4 over a period of 24 hours before f.f.u. 
titering on Hep-2 cells. Percent reductions in titer were reported for each time relative to 
the titer as determined before incubation (day 0). Error bars represent mean percent 
reductions in titer compared to hour 0. No statistically significant difference was 
observed between strains at any pH level.  
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DISCUSSION  
Understanding the Role of pH  
 We hypothesized that strain-specific differences in stability likely attribute to 
differences in RSV F protein, as suggested by previous studies. However, no significant 
difference was observed in stability due to changes in pH, as expected. Minor variations 
were observed between strains with regard to tolerance of pH, however high level 
structures and configurations of these proteins may not vary significantly as shown 
through available crystal structures. The averaged, optimal pH for RSV was found to 6.9, 
which is close to neutral (TABLE 1). This finding is in agreeance with results of previous 
studies completed by Long laboratory (Hambling, 1964). No current studies have 
reported the optimal stability for RSV G with regard to pH, however, early studies of 
RSV F protein have indicated that near neutral pH is ideal, which is consistent with the 
findings in this study. Through pH didn’t demonstrate significant different in replication 
ability of the virus, thermal stability and syncytia formation were shown to have 
statistical significance. This suggests that thermal stability may play an integral part in 
the altering the function of RSV F protein. Previous studies have demonstrated there is 
strain-specificity associated with temperature (Stobart et al., 2016). This data and 
previous studies suggest that RSV F protein in mediating the stability of the virus.  
 
Impact on Stability  
While clinical isolate collections continue to grow, very little is known regarding 
the differences in physicality and function between the viral strains. Through examining 
one aspect of physical instability, such as pH, will allow for further understanding of the  
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Table 1. Summary of the physical and functional characteristics of a panel of 
recombinant RSV viruses differing in G and/or F protein expression (DeFord et al., 
2019) 
The average values for each of the viruses and the average for the entire panel are 
















  Nosek  34 
variations found in RSV F and G gene expression and their effects on replication and 
stability of RSV. RSV F protein stability can have large impact in the way in which 
therapeutic options are handled to a cellularly level. By pinpointing the aspect controlling 
stability, RSV F can become a prime target for antiviral drugs, and more importantly, a 
vaccine. Viral stability is crucial in order that the infection continue and spread to 
uninfected cells. If the RSV F protein is altered in a way that would not allow for it to 
undergo a conformational change and permit fusion, the process of pathogenesis is 
essentially halted. In addition, the resounding effects would be seen in the viral stability 
in various ways, in what ways I don’t know, but ways.  
 
Application in Vaccine Studies  
 The development and production of a vaccine for RSV, especially for the young 
infant population, remains a paramount goal amongst the international public health 
community despite the intrinsic instability of the virus. An ideal target for vaccine 
development would be RSV F due to its ability to elicit an immunogenic response, but 
also control the stability of the virus. Further information regarding the role of RSV G 
would provide further information for the vaccine as it also plays a role in attachment of 
the virus, however, further studies are needed.  
 Finding and producing a vaccine for RSV would lead to a significant decrease in 
hospitalizations and mortality in target populations (FIGURES 5 and 14). In addition, it 
would also life-long protection against this virus. However, the journey to designing, 
producing, and delivering a vaccine can be quite long. The current pandemic is a perfect 
example for this. After a stable, efficacious vaccine has been designed and produced,  
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FIGURE 14: Relationship Between Mortality, Hospitalization, and Global Incidence 
of RSV (Mazur et al., 2018)  
The figure above highlights the connections between global incidence of RSV and the 
number of hospitalizations and mortality from RSV, providing critical information 
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introducing into human populations can pose as a challenge. Support for receiving this 
vaccine is the first major obstacle. Since RSV’s target population is young infants, it will 
be crucial to have the support of pediatricians and family doctors to help garner support 
for the vaccine and increase the amount of individuals who receive the vaccine during its 
introduction until becoming commonplace. This could be met with resistance by anti-
vaxxer groups, who do not support the use of vaccines due to false reports of vaccines 
causing autism that circulated in the 2010s. 
 Another potential problem that could arise in the administration of the vaccine 
might be seen in the transport and storage of the vaccine to developing areas. While 
developed countries have significant less difficulties in vaccine storage and transport, 
developing countries may experience problems in these sectors at a higher rate. An 
example demonstrating how transport may be a potential problem is through polio 
vaccine transport and delivery. Currently, polio is the next virus to be eradicated from the 
planet, however, due to warring factions in the mountainous borders of Nepal and Iraq, 
vaccine delivery in this area is not possible, thus polio is still present in these areas. RSV 
vaccine delivery may experience similar difficulties as the world political sphere 
progresses in the coming years. Storage of the vaccine may pose a threat as well. Storage 
of vaccines usually occurs around 4°C, however, facilities or machinery to allow for this 
storage may not be available in developing areas. The data presented in this study and in 
Deford et al., 2019 present information that can be utilized in vaccine design to increase 
stability at all temperatures to create a vaccine that will not degrade due to storage.  
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Future Directions   
 Looking to the future, further experiments can still be conducted in regards to 
physical stability of RSV. Surface exposure and salinity studies have yet to be studied 
regarding and would provide immensely important information on RSV transmission, 
stability in the environment, proper sanitation and cleaning techniques for areas that 
experience high levels of younger populations like daycares. Studies looking at the 
transmissibility of RSV from host to host would also be beneficial as it would provide 
further information on control of the virus and mitigating spread in high risk populations. 
These studies could also inform vaccine design and production to create more stable 
vaccines to deliver to developing nations that may not have proper storage facilities.  
Other directions lie with a very similar virus, human metapneumovirus (hMPV), 
an enveloped, negative sense single-stranded RNA virus (-ssRNA). It was not until 2001 
that hMPV was discerned through further genetic analysis as it was previously thought to 
be a weaker form of RSV. However, recent studies of hMPV have revealed very similar 
genomic composition and disease progression as seen in RSV (FIGURE 15). hMPV and 
RSV both share the F protein structure and function suggesting that the studies conducted 
in RSV regarding viral stability could be similar to that of hMPV. Furthermore, target 
populations are the same, meaning a vaccine that could provide protection against both 
RSV and hMPV would be crucial in mitigating infant mortality through respiratory 
pathogens. Currently, the environmental stability of hMPV has been limited to 
exploration in UV exposure and freeze-thaw assays to understand the effect on freezing 
viral stock. Understanding the viral stability of hMPV with regard to temperature, surface 
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exposure, salinity, and pH will provide further information of the roles of the F protein 
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FIGURE 15: Comparative Genome Depiction of RSV and hMPV (ICTV)  
This schematic depicts the genomes of RSV and hMPV and demonstrates the similarity 
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